Indefinite Delivery Contract 75F40121D00007

Award Date 3/31/21
Last Date to Order 3/30/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
Pacific Biosciences of California, Inc. has been awarded a $13.5 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract by the USDA Agricultural Research Service to provide specialized scientific equipment, reagents, and services associated with the company's Sequel and Sequel II DNA/RNA sequencing platforms. This long-term contract vehicle allows the USDA to issue multiple delivery orders for PacBio's high-throughput, long-read sequencing systems, consumables, and...
The U.S. Food and Drug Administration (FDA), a civilian agency, has awarded an Indefinite Delivery Contract to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $25,000,000 and a period of performance through January 29, 2028. Under this contract, Illumina will provide the FDA with a variety of its proprietary reagent chemistry kits and associated consumables to support the agency's laboratory testing,...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the provision of Reagent (Chemistry) Kits. The single-award IDC has a ceiling value of $19,500,000 and an ultimate completion date of September 14, 2022. Under this contract, the FDA has issued a series of firm fixed-price delivery orders to Illumina for the supply of various chemistry...
The U.S. Food and Drug Administration (FDA), a civilian federal agency, awarded a single-award Indefinite Delivery Contract (IDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $1,250,000 IDC is for the procurement of laboratory services and Qiagen's molecular biology and sequencing library reagents. Under this IDC, the FDA has issued several firm fixed-price delivery orders for Qiagen to provide a variety of molecular biology reagents, extraction and...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $992,022 IDC provides for the delivery of NextSeq 500 High Output Reagent Kits to support the FDA's nucleic acid sequencing needs, with no set-aside provisions. Three delivery orders have been issued against the IDC, valued at $38,896, $193,380, and $237,188 respectively, for the purchase of...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Molecular Epidemiology Inc. to provide microbiological analysis and whole genome sequencing services. The single award IDV has a potential value of $10 million and a period of performance through May 2027. Five firm fixed price task orders have been issued against the contract to date for specific services. These include analysis of Cyclospora cayetanensis oocysts, shrimp...
This Indefinite Delivery Contract was awarded by the U.S. Department of Agriculture (USDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $35,000,000 and a period of performance through May 25, 2025. Under this contract, Illumina provides a range of laboratory equipment, consumables, and services to support the USDA's research and diagnostic needs. This includes the provision of Illumina's NextSeq, NovaSeq,...
The key products and services being delivered under this Indefinite Delivery Contract (IDC) awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) are proteomics analysis services on human plasma and serum samples. The prime contractor, Somalogic Operating Co., Inc. (doing business as CM Life Sciences II Inc.), is a commercial-stage proteomics company that provides its proprietary SomaScan platform to measure thousands of proteins in small biospecimens....
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Contract (IDC) to AB Sciex LLC, a division of Danaher Corporation, for a 5-year maintenance and service contract for liquid chromatography-tandem mass spectrometers (LC-MS/MS). The contract has a ceiling value of $2,503,000 and a period of performance through April 23, 2029. Under this IDC, the FDA awarded a $225,566.45 Firm Fixed Price Delivery Order to AB Sciex LLC for an...
The National Institute of Standards and Technology (NIST), a civilian federal agency, awarded a Blanket Purchase Agreement (BPA) contract to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The BPA allows NIST to quickly procure Illumina's proprietary sequencing systems, reagents, and consumables to support their genomic research and analysis needs. Under this BPA, NIST has issued multiple firm fixed price call orders to Illumina, with a total contract...
  • 75F40121D00007
    Indefinite Delivery Contract
  • 8
    Federal Contract Awards

The U.S. Food and Drug Administration (FDA) has awarded a $1 million single-award Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Pacific Biosciences of California, Inc. to provide sequencing reagents, kits, and consumables to support the agency's genomic research and regulatory review activities. Under this contract, the FDA has issued multiple delivery orders for the purchase of Pacific Biosciences' proprietary single molecule, real-time (SMRT) sequencing consumables, including template preparation kits, binding kits, SMRT cells, and associated reagents. These supplies are used with Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing platforms, which are widely utilized across federal research programs in areas such as agriculture, infectious diseases, and biotechnology. The contract allows the FDA to acquire these specialized sequencing products on an as-needed basis through March 2025, with no socioeconomic set-asides applied. The place of performance for the delivery orders is at FDA facilities in Maryland. Pacific Biosciences has a strong track record of supporting federal agencies' scientific initiatives, having fulfilled over $10 million in sequencing equipment and consumables contracts with the Departments of Agriculture, Health and Human Services, and Defense.

Generated 3/14/25, 9:54 AM